Immunologic effects of TCDD exposure in humans.
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects; D002648:Child; D004147:Dioxins / Q000009:adverse effects*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D007113:Immunity, Innate / Q000187:drug effects; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D051379:Mice; D008923:Missouri; D010865:Pilot Projects; D000072317:Polychlorinated Dibenzodioxins / Q000009:adverse effects* / Q000633:toxicity; D012882:Skin Tests; D013601:T-Lymphocytes / Q000187:drug effects
D004147:Dioxins; D000072317:Polychlorinated Dibenzodioxins